These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 1314099

  • 1. Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users.
    Williams AB, McNelly EA, Williams AE, D'Aquila RT.
    AIDS Care; 1992; 4(1):35-41. PubMed ID: 1314099
    [Abstract] [Full Text] [Related]

  • 2. Factors associated with client-reported HIV infection among clients entering methadone treatment.
    MacGowan RJ, Fichtner RR, Swanson N, Collier C, Kroliczak A, Cole G.
    AIDS Educ Prev; 1997 Jun; 9(3):205-17. PubMed ID: 9241388
    [Abstract] [Full Text] [Related]

  • 3. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL, London J, Heitzmann C, Gibson DR, Morales ES, Dumontet R, Acree M.
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [Abstract] [Full Text] [Related]

  • 4. Preparations for AIDS vaccine trials. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs.
    Marmor M, Titus S, Wolfe H, Krasinski K, Maslansky R, Simberkoff M, Beatrice S, Nichols S, Des Jarlais DC.
    AIDS Res Hum Retroviruses; 1994 Apr; 10 Suppl 2():S207-13. PubMed ID: 7865302
    [Abstract] [Full Text] [Related]

  • 5. Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program.
    Millson P, Challacombe L, Villeneuve PJ, Strike CJ, Fischer B, Myers T, Shore R, Hopkins S.
    AIDS Educ Prev; 2007 Apr; 19(2):124-36. PubMed ID: 17411415
    [Abstract] [Full Text] [Related]

  • 6. Methadone maintenance therapy outcomes in Iran.
    Noori R, Narenjiha H, Aghabakhshi H, Habibi G, Khoshkrood Mansoori B.
    Subst Use Misuse; 2012 Jun; 47(7):767-73. PubMed ID: 22416897
    [Abstract] [Full Text] [Related]

  • 7. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.
    Hartel DM, Schoenbaum EE.
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):107-15. PubMed ID: 9722816
    [Abstract] [Full Text] [Related]

  • 8. [A prospective cohort study on human immunodeficiency virus and syphilis seroconversion among injecting drug users].
    Yin L, Qin GM, Ruan YH, Zhang L, Hao QN, Chen XH, Jiang ZQ, Song BL, Liu SZ, Cao XY, Hao C, Chen KL, Shao YM.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Apr; 27(4):293-7. PubMed ID: 16875529
    [Abstract] [Full Text] [Related]

  • 9. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md.
    Nelson KE, Vlahov D, Solomon L, Cohn S, Muñoz A.
    Arch Intern Med; 1995 Jun 26; 155(12):1305-11. PubMed ID: 7778962
    [Abstract] [Full Text] [Related]

  • 10. Safe sex? Misconceptions, gender differences and barriers among injection drug users: a focus group approach.
    Weiss SH, Weston CB, Quirinale J.
    AIDS Educ Prev; 1993 Jun 26; 5(4):279-93. PubMed ID: 8297708
    [Abstract] [Full Text] [Related]

  • 11. Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study.
    Serpelloni G, Carrieri MP, Rezza G, Morganti S, Gomma M, Binkin N.
    AIDS Care; 1994 Jun 26; 6(2):215-20. PubMed ID: 8061081
    [Abstract] [Full Text] [Related]

  • 12. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection.
    Dolan KA, Shearer J, White B, Zhou J, Kaldor J, Wodak AD.
    Addiction; 2005 Jun 26; 100(6):820-8. PubMed ID: 15918812
    [Abstract] [Full Text] [Related]

  • 13. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S, Panda S, Sarkar K, Hangzo CZ, Bijaya L, Singh NY, Das N, Agarwal A, Chatterjee A, Deb BC.
    Indian J Public Health; 1995 Jun 26; 39(3):86-92. PubMed ID: 8690497
    [Abstract] [Full Text] [Related]

  • 14. No seroconversions among steady sex partners of methadone-maintained HIV-1-seropositive injecting drug users in New York City.
    Siddiqui NS, Brown LS, Phillips RY, Vargas O, Makuch RW.
    AIDS; 1992 Dec 26; 6(12):1529-33. PubMed ID: 1492936
    [Abstract] [Full Text] [Related]

  • 15. Relationship of HIV testing and high-risk behaviors among clients in methadone maintenance treatment.
    Grella CE, Campos M, Anglin MD.
    AIDS Educ Prev; 1998 Oct 26; 10(5):403-16. PubMed ID: 9799937
    [Abstract] [Full Text] [Related]

  • 16. Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies.
    Miller CL, Kerr T, Frankish JC, Spittal PM, Li K, Schechter MT, Wood E.
    Subst Use Misuse; 2006 Oct 26; 41(2):199-210. PubMed ID: 16393742
    [Abstract] [Full Text] [Related]

  • 17. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
    Mark HD, Nanda J, Davis-Vogel A, Navaline H, Scotti R, Wickrema R, Metzger D, Sochalski J.
    Public Health Nurs; 2006 Oct 26; 23(1):11-9. PubMed ID: 16460416
    [Abstract] [Full Text] [Related]

  • 18. Injection drug users' experience with and attitudes toward methadone clinics in Denver, CO.
    Al-Tayyib AA, Koester S.
    J Subst Abuse Treat; 2011 Jul 26; 41(1):30-6. PubMed ID: 21371849
    [Abstract] [Full Text] [Related]

  • 19. On-site medical care in methadone maintenance: associations with health care use and expenditures.
    Gourevitch MN, Chatterji P, Deb N, Schoenbaum EE, Turner BJ.
    J Subst Abuse Treat; 2007 Mar 26; 32(2):143-51. PubMed ID: 17306723
    [Abstract] [Full Text] [Related]

  • 20. Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study.
    Lamothe F, Bruneau J, Coates R, Rankin JG, Soto J, Arshinoff R, Brabant M, Vincelette J, Fauvel M.
    CMAJ; 1993 Oct 01; 149(7):945-51. PubMed ID: 8402423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.